News | 26 November 2012
Based on detailed review and analysis of modern claims-based adherence literature and data, the estimate of revenue lost by the U.S. pharmaceutical industry each year due to non-adherence to medications for chronic disease is $188 billion. Extrapolated ...
Click on the link to read the full article at Sacramento Bee
(This link will open in a new window)